David Siffert, legal director at S.T.O.P., discusses 23andMe’s possible bankruptcy along with the potential legal fallout and ...

In the wake of 23andMe's big data breach and major layoffs, many people are now eager to jump ship from the company and take ...

It remains unknown how many patients are affected by the incident. The Qilin ransomware group claims to have leaked 400 ...

23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company's stock hit a rock-bottom of US$0.30 ...

The judge declined to grant a proposed injunction, allowing 16,000 arbitrating plaintiffs to be excluded, despite 23andMe’s pleas that doing so could cost more than $30 million in filing fees.

23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...

Just over a year ago, 23andMe’s co-founder and CEO Anne Wojcicki was assuring the life sciences industry that the company was a “full-fledged biotech” committed to drug R&D. “We have real ...

Vertical farms, woke AI, and 23andMe made our annual list of failed tech. They say you learn more from failure than success.

As the U.S. stock market looks to recover from a recent losing streak, with major indices like the Dow Jones and Nasdaq showing signs of strength, investors are exploring diverse opportunities across ...

The 23andMe Health + Ancestry Personal Genetic DNA Test offers just that — an opportunity to kickstart these goals by providing valuable insights into your genetic makeup and ancestral origins.